Data from Virginia Commonwealth University Broaden Understanding of Breast Cancer (Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer).

Breast Cancer, Cancer, Drugs and Therapies, Genetics, Health and Medicine, Oncology, Women's Health Although these observations suggest a pan-breast cancer utility for proteasome inhibitors, our further experiments with breast cancer cell lines and patient-derived xenografts (PDX) pointed to triple-negative breast cancer (TNBC) as the most sensitive subtype to proteasome inhibition. Keywords: Breast Cancer; Cancer; Drugs and Therapies; Genetics; Health and Medicine; Oncology; Women's Health EN Breast Cancer Cancer Drugs and Therapies Genetics Health and Medicine Oncology Women's Health 242 242 1 10/09/23 20231013 NES 231013 2023 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on breast cancer. [Extracted from the article]